Bausch Health Companies Inc. (BHC) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-03

Key Insights

Jean-Jacques Charhon, the Executive Vice President and CFO of Bausch Health Companies Inc., disposed of 49,060 common shares on 02/27/2026 to satisfy tax withholding obligations, reducing his direct ownership to 706,478 shares.
The sale appears to be a routine stock disposition to cover tax liabilities and not an unusual or concerning insider transaction.
Investors should monitor any future insider trading activities by Charhon and other key executives for potential signals about the company's financial health or management's confidence in the stock.

Want the newest filings?

This analysis covers the filing from 2026-03-03. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-03

The reporting person, Seana Carson, an EVP and General Counsel at Bausch Health Companies Inc. (BHC), has engaged in a series of transactions involving the company's common shares, including share disposals and tax withholding.
Carson has adopted a Rule 10b5-1 trading plan to sell shares, indicating planned and structured insider activity.
The reporting person has also received and disposed of performance share unit awards, which were paid out in cash rather than stock, as previously disclosed by the company.

Filed: 2026-03-03

The reporting person, Thomas Appio, the Chief Executive Officer of Bausch Health Companies Inc. (BHC), has disposed of a significant number of company shares through a combination of share withholding and cash settlement of performance share units.
The share dispositions suggest Appio is reducing his direct ownership stake in the company, potentially for personal or diversification reasons.
The settlement of performance share units in cash rather than stock, as previously reported, indicates a change in the company's equity compensation practices.

Filed: 2026-02-27

Jean-Jacques Charhon, the EVP and CFO of Bausch Health Companies Inc., acquired 276,055 common shares of the company through a restricted share unit (RSU) award, increasing his beneficial ownership to 755,538 shares.
Charhon also disposed of 35,977 common shares to satisfy tax withholding obligations upon the vesting of his RSUs, indicating a potential need for liquidity.
The timing of this transaction, occurring in February 2026, suggests the company may be providing equity-based compensation to its executive team, aligning their interests with shareholders.

Filed: 2026-02-27

Steven Hyosig Lee, the SVP, Controller & CAO of Bausch Health Companies Inc., has been granted 45,868 restricted share units (RSUs) that will vest over the next three years.
This insider award indicates the company's commitment to retaining and incentivizing its key executive, which could be positive for investor confidence.
The RSU grant is significant, as it represents a meaningful portion of the executive's current beneficial ownership of 73,239 common shares.

Filed: 2026-02-27

The reporting person, Aimee J. Lenar, was awarded 157,139 restricted share units (RSUs) by Bausch Health Companies Inc. (BHC), indicating the company is providing equity-based compensation to its executives.
Lenar sold 17,578 common shares of BHC, likely to cover tax withholding obligations upon the vesting of the RSUs, suggesting she is actively managing her equity position in the company.
The RSUs granted to Lenar will vest over a three-year period, aligning her interests with long-term shareholders and incentivizing her to drive the company's performance.

Filed: 2026-02-27

The reporting person, Seana Carson, who is the EVP and General Counsel of Bausch Health Companies Inc. (BHC), acquired 212,350 common shares through a restricted share unit (RSU) award on February 25, 2026.
On February 26, 2026, Carson disposed of 32,211 common shares to satisfy tax withholding obligations upon the vesting of the RSUs.
On February 27, 2026, Carson sold 8,388 common shares in the open market pursuant to a Rule 10b5-1 trading plan established on May 7, 2025.

Filed: 2026-02-27

THOMAS APPIO, the Chief Executive Officer of Bausch Health Companies Inc. (BHC), acquired 815,425 common shares through a restricted share unit (RSU) award, increasing his direct ownership to 3,736,536 shares.
APPIO also disposed of 116,502 common shares to satisfy tax withholding obligations upon the vesting of his RSUs, reducing his direct ownership to 3,620,034 shares.
The RSU award and subsequent share disposition suggest APPIO's continued commitment to and confidence in Bausch Health's long-term growth and performance.

Filed: 2026-01-02

The reporting person, Amy B. Wechsler, acquired 989 common shares of Bausch Health Companies Inc. (BHC) on December 31, 2025, increasing her direct ownership to 266,441 shares.
The shares were acquired as restricted share units issued in lieu of cash compensation for the reporting person's service on the company's Board of Directors for the quarter ending December 31, 2025.
This transaction indicates the reporting person's continued involvement and confidence in the company's leadership and future prospects.

Filed: 2026-01-02

John Paulson, a director of Bausch Health Companies Inc. (BHC), acquired 8,992 common shares through restricted share units issued as part of his board compensation on 12/31/2025.
Paulson's total direct ownership in BHC increased to 360,120 common shares, while he also holds an indirect beneficial ownership of 73,255,869 shares through managed funds.
The insider buying activity suggests Paulson's confidence in the company's prospects, as he increases his personal stake in BHC.

Filed: 2026-01-02

The reporting person, Sandra Leung, acquired 4,586 common shares of Bausch Health Companies Inc. (BHC) on 12/31/2025, increasing her direct beneficial ownership to 38,408 shares.
The shares acquired were granted as restricted share units in lieu of cash compensation for her service on the company's board of directors.
This insider transaction indicates ongoing engagement and confidence in the company by a member of the board of directors.

Other reports for Bausch Health Companies Inc.

Quarterly Report Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.